Challenges in Measles Outbreak Responses MSF Perspectives Florence Fermon - Myriam Henkens 10th Annual Measles Initiative Meeting 14/09/2011.

Slides:



Advertisements
Similar presentations
Socio Economic study of meningitis epidemic Anaïs Colombini, AMP GEO meningitis meeting September, 2007.
Advertisements

Global Measles and Rubella Strategic Plan
Measles elimination in the African Region- Regional updates
Immunization Services DR. KANUPRIYA CHATURVEDI DR.S.K. CHATURVEDI.
Measles Outbreaks in Southern Africa in 2010 Presentation to the MI 10 th annual meeting Sept 2011 B Masresha WHO AFRO.
1 Dr. Azhar Abid Raza Washington Sept 2011 Measles elimination in Pakistan.
Assessment of PEPFAR’s Impact on Selected Health System Parameters in Sub-Saharan African Countries Presented by: Anya Shen Viviane D. Lima, Wendy Zhang,
Interagency Contingency Planning and Emergency Preparedness: Challenges and Lessons Learnt V. Harutyunyan M.D. Head of Health / Merlin Global Nutrition.
Measles outbreak investigation & Response Jordan DR MOHAMAD RATIB SUROUR NATIONAL EPI MANAGER INTER-COUNTRY MEETING ON MEASLES AND RUBELLA CONTROL AND.
The Cape Verde experience with rubella outbreak & lessons from introducing rubella vaccines MoH Cape Verde ARCI meeting Dar es Salaam, Tanzania Dec 2012.
Malaria Control and Evaluation Partnership for Africa (MACEPA) National Scale-up of Malaria Prevention and Control A Learning Community RBM Board Meeting:
Global Measles and Rubella Management Meeting Progress and Challenges in Bangladesh March, 2011 Geneva, WHO HQ Dr Serguei Diorditsa.
Invalid MCV1 doses – how big a problem? B Masresha WHO AFRO AFR MR TAG Meeting Nairobi, June 2015.
Measles vaccination in MSF context: priorities, results and challenges/concerns AFRICAN REGIONAL MEASLES-RUBELLA TAG MEETING Nairobi, June 2nd-3rd 2015.
WHO RAP Team: Perspective and Update WORKSHOP ON ANALYZING THE POLIO ERADICATION ENDGAME, Seattle, 1-2 July 2015.
Do we need a measles vaccine stockpile for more effective measles outbreak response? Global Measles and Rubella Management Meeting Global Measles and Rubella.
Africa Herbal Antimalaria Meeting Nairobi, March 2006 Research on Traditional Medicines used for the Treatment of Malaria in WHO African Region Traditional.
Departmental Perspectives on Viral Hepatitis
1 AFRO Measles TAG – Nairobi 2-3 June 2015 MCV2 Introduction and the Second Year of Life Contact Lessons and way forward Raoul KAMADJEU UNICEF ESARO Meeting.
A Comprehensive Policy framework for the National Immunization Programme Dr Nihal Abeysinghe, [M.B.,B.S., MSc, M.D.] Chief Epidemiologist, Ministry of.
IATT Annual Meeting Adolescent and Young People participation In the fight against HIV/AIDS in Africa Presented by: Ms. Aidah Nakanjako AfriYAN April 16,
Harold S. Margolis, M.D. Division of Viral Hepatitis
Polio Update Pre Tender Meeting 11 th December 2008 UNICEF Supply Division.
Measles Initiative Financing February 28, 2007 Washington, D.C. Andrea Gay UN Foundation for Measles Partners.
1 1 Measles elimination and rubella control in the SEA Region- a brief Update 12 th Annual Meeting of the Measles Rubella Initiative (MRI) September,
PolioPlus Progress Last wild poliovirus type 2 in the world Aligarh, India.
1 Progress Towards Polio Eradication in EMR. 2 Status of global eradication Priority countries (except EMR) : Intensification : Certification,
Measles Vaccination in Epidemic Contexts RF Grais, ACK Conlan, MJ Ferrari, C Dubray, A Djibo, F Fermon, M-E Burny, KP Alberti, I Jeanne, BS Hersh, PJ Guerin,
Conclusions of the meeting and closing remarks. Chronology 1981Hepatitis B vaccine becomes available 1991World Health Assembly resolution call for the.
JAHSR TECHNICAL REVIEW MEETING EPI Report Dr Dafrossa C Lyimo Programme Manager 7th September 2010 Dar es salaam.
Measles elimination Dr. As’ad Ramlawi Palestine..
Implementing the revised TB/HIV indicators and data harmonisation at country level Christian Gunneberg MO WHO Planning workshop to accelerate the implementation.
Funding Update: 2013 – 2015 September 10,
PEPFAR Investment Strategy (8 years of PEPFAR) Data source : OGAC Budget Total PEPFAR Investment: $21,285,918,291 Saving Lives : Changing the.
Measles pre-elimination in the African Region. Presentation to the MI 10 th annual meeting Sept 2011 B Masresha WHO AFRO.
1 |1 | Measles pre-elimination and resurgence in the African region Balcha Masresha IVD AFRO Global Measles Management Meeting Geneva March 2011.
Future plans Dr Wendy Harrison Managing Director, Schistosomiasis Control Initiative, School of Public Health, Imperial College London SCI Open Evening,
Sudan EPI Benefits From Polio Eradication Program M&RI Annual Partners Meetings Washington D.C September 2015 Sudan EPI Benefits From Polio Eradication.
MR introduction and rubella epidemiology in AFRO Regional MR TAG Nairobi, Kenya June 2-3, 2015.
Update on Progress toward Measles Situation in EMR September 2008 Dr B. Naouri VPI/DCD/EMRO.
Gavi’s Measles and Rubella Programme:Update Stefano Malvolti September 2015, Washington DC Page: 1 Reach every child.
Measles Mortality Reduction: the risk of resurgence Global Immunization Meeting Geneva, Switzerland 1-3 February 2010 Balcha Masresha, WHO/AFRO.
2015 Measles & Rubella Initiative Annual Partners Meeting, Human & Financial Costs of Measles and Rubella, 15 September 2015, Washington, DC Achieving.
A global partnership to stop measles & rubella 1 Measles & Rubella Initiative --Who We Are-- Stephen Cochi, MD, MPH Global Immunization Division Centers.
12 th Annual Meeting of The Measles & Rubella Initiative American Red Cross, Washington, DC September, 2013.
Global and Regional Perspective on Maternal, Infant & Young Child Nutrition: Overview of Progress and way forward for Sustainable Development Goals Ms.
Measles and Rubella Initiative Financial Resource Requirements for Measles and Rubella Annual Partners Meeting, September
1 MUTUAL ACCOUNTABILITY: LESSONS FOR POST-BUSAN PROGRESS Matthew Martin Director Development Finance International DfID Mutual Accountability Seminar 14.
What Will it Take to Reach the Fast Track Prevention Targets? July 18, 2016, International AIDS Conference Karl L. Dehne, Chief Prevention, UNAIDS.
Global Measles and Rubella: Highlights, Priorities and Critical Issues
Global Overview of Measles
CommCare 101: The PMI AIRS Project Supervisory Tool
Routine Immunization System during an M/R SIA?
WHO AFRO Technical Coordinator for Health Emergencies
World Health Organization
Measles & Rubella Initiative Partners meeting September 7-8, 2017
POLIOPLUS FACT SHEET Feb 2018
Progress and Challenges with achieving Universal Immunization Coverage
23 November, 2018 Update on measles & rubella surveillance in the WHO African Region – progress and challenges Dr Richard Luce WHO/IST-Central 5th African.
African Region- priorities to reach the 2020 measles elimination goal.
Experience with the measles outbreak response fund
Reported measles cases, measles coverage for 1st and 2nd doses and supplementary measles activities for the African Continent For 1990 – 2007 Data as of.
Essential Drugs and Medicines Policy (EDM) World Health Organization
Polio Eradication and STOP Program
Pediatric HIV Case Finding Strategies
State of Measles Initiative Financing Partners for Measles Advocacy Meeting Washington, D.C. September 22, 2008 Andrea Gay.
Maintaining Elimination in an Environment of Persistent Importation
YELLOW FEVER VACCINE AVAILABILITY AND NEEDS FOR THE AFRICAN REGION
Kenya Pediatric Association Conference,
Chief, Meningitis and Vaccine Preventable Diseases Branch
Presentation transcript:

Challenges in Measles Outbreak Responses MSF Perspectives Florence Fermon - Myriam Henkens 10th Annual Measles Initiative Meeting 14/09/2011

Measles resurgence in Africa Resurgence comes after a period of intensified efforts –Since 2000, routine measles vaccination coverage has increased from an estimated 52% to 85% In 2009, 30 African countries experienced measles outbreaks –>60,000 reported cases and >1000 reported deaths (WHO) In 2010, 28 countries experienced measles outbreaks –223,000 reported cases and 1200 deaths (WHO) Real numbers of measles cases and deaths are considerably larger than the numbers reported WHA resolution (RC61) calls for measles elimination in AFRO by 2020

Why the resurgence? 1.Build-up of susceptible children and adolescents 2.Failure to vaccinate rather than vaccine failure 3.Programmatic, political and financial challenges

1. Susceptibility build up Two sources of immunity Natural immunity due to infection Vaccine derived immunity As vaccination increases Less circulating virus Age distribution of cases changes - a natural consequence of the success of vaccination programs –Children (on average) are older when they become infected

Different age distributions Malawi: 2010 Burkina Faso: 2009 Niger: 2004DRC: 2006 In endemic countries, outbreaks are limited to young age classes. Outbreaks in countries following “elimination” extend evenly age classes Countries in transition are intermediate Source: courtesy Matthew Ferrari

2. Failure to vaccinate rather than vaccine failure Source: VC(WHO and MICS 2010), cases: Rapports épidémiologiques annuels, 4ème direction, RDC

Programmatic, political and financial challenges Measles victims of MI success and outbreak responses low on politicians and donors agenda Delays/reluctance in implementing outbreak responses, despite international recommendations Lack of efficient coordination Lack of rapid funding Delays in implementing campaigns - SIAs – despite strong international support (vaccines and operating costs) DRC 2010 => outbreak 2011

MSF & measles outbreak responses Surveillance, treatment, vaccination (when authorized) 2009: Chad, Ethiopia, DRC, Pakistan, Bangladesh, Nigeria, Sudan, Burkina Faso –1.4 million vaccinated, treated 2010: Malawi, Chad, DRC, Ethiopia, Yemen, Zimbabwe, Mozambique, Burundi, South Africa, Somalia, Zambia –4.6 million vaccinated treated 2011: DRC Bangladesh Burundi, Chad, Ethiopia, Kenya, Niger, Somalia, Zambia –already 3 million vaccinated in DRC only, more than 4 million total in August –More than treatments in DRC only

Measles outbreak responses in Africa Persons vaccinated – MSF On going - DRC - Burundi - Chad - Ethiopia - Kenya - Niger - Nigeria - Somalia - Zambia

Challenges 1.Outbreak detection and recognition 2.Outbreak response plan 3.Outbreak response implementation 4.Outbreak prevention

1. Outbreak detection & recognition Inaccurate (inflated) vaccination coverage data  biased risk assessment Weak surveillance system  late detection of increase in case number Outbreaks = “failure to vaccinate”  late official recognition of outbreak (MOH and main actors) But outbreaks do and will occur in many countries

Measles resurgence in Europe/USA

2. Outbreak response plan Lack of knowledge of the WHO recommendations Lack of knowledge of the usefulness of vaccination in outbreak No standard tools nor technical recommendations for reactive campaigns Lack of organized technical support (measles >< polio or meningitis)

3. Outbreak response implementation Coordination between the different partners Competition with other priorities (polio campaigns) Free treatment, increased access to treatment Timely vaccines availability Timely funding

4. Outbreak prevention Maintain the number of susceptibles as low as possible EPI –Flexibility in age range –Immunization included in comprehensive package of care –Special approach to reach children never vaccinated (“reach the un reached”) –Reduce missed opportunities (surveys, health care contacts, etc) –More accurate data in performance, coverage, etc

Reaching the unreached Before Campaign After Campaign Card % (95% CI) 7.6 ( ) 5.5 ( ) 53.0 ( ) 40.2 ( ) Card/Recall % (95% CI) 33.0 ( ) 68.7 ( ) 80.6 ( ) 81.1 ( ) Vaccination coverage before and after campaign (6-59 m), Ndjamena, Chad

Lessons learned, N’djamena, Chad Chronically low vaccine coverage –Failure to reach older children through routine services –Measles-susceptibles built up and to precipitate the 2010 epidemic 18% received their first dose in 2010 –previously vaccinated children were easier to reach during the outbreak than unvaccinated children

Missed opportunities CAR - Paoua and Congo Brazza - Betou (MSF ) –limited access to care areas –children were not offered vaccination (in or outpatients) –0 to 11 m: 65 to 94% were not immunized according to recommendations –12 to 59 m: 86% to 98% were not immunized and could not be according to the EPI schedules

4. Outbreak prevention (2) SIA / vaccination campaign –Implement TAG recommendations and adjust age group to local epidemiology –Fixed duration of campaigns >< coverage reached –Adapt SIA intervals to needs –Accurate data collection –Independent coverage surveys –Implementation according to plan (DRC 2010)

What could be done? Outbreak response included as a component of the Measles Initiative Outbreak response included into national control programs Renewed political and financial commitment Strategies to ensure countries implement SIAs according to plan Improved coordination in country – Meningitis and Polio could be used as example Limitations / constraints of implementing recommended strategies should be acknowledged

What could be done? (2) Creative strategies –to reduce the missed opportunities, –to reach the unreached Consider multi Ag campaign (polio, MenA conj, etc) Develop a risk assessment tool (susceptible population, social determinants, operational strategy) Develop supporting tools/documents (WHO 2009 recommendations in French, practical accompanying document) Financial mechanism for rapid response New vaccines (easy to administer, no cold chain, etc)

Acknowledgments MSF teams – field and HQ Epicentre (Rebecca Grais, Andrea Minetti) Matthew Ferrari Thank You For Your Attention